Front Line Medical Technologies

Front Line Medical Technologies today announced it received CE mark approval for its COBRA-OS device.

The CE mark gives EU medical providers access to the Control Of Bleeding, Resuscitation, Arterial Occlusion System (COBRA-OS). The device already has FDA clearance and Health Canada approval.

“The CE marking of the COBRA-OS is momentous for our company, as it reinforces our dedication to technological excellence and our unwavering commitment to better patient care,” CEO Dr. Asha Parekh said in a news release. “Day in and day out, our pursuit of helping to save as many lives as we can is what drives our entire team, and this regulatory achievement means we are further on our way to accomplishing that goal.”

COBRA-OS is a 4 Fr aortic occlusion device that doesn’t require an over-the-wire technique. The company said it is one of the smallest life-saving Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) devices c…

Front Line Medical Technologies today announced it received CE mark approval for its COBRA-OS device.

The CE mark gives EU medical providers access to the Control Of Bleeding, Resuscitation, Arterial Occlusion System (COBRA-OS). The device already has FDA clearance and Health Canada approval.

“The CE marking of the COBRA-OS is momentous for our company, as it reinforces our dedication to technological excellence and our unwavering commitment to better patient care,” CEO Dr. Asha Parekh said in a news release. “Day in and day out, our pursuit of helping to save as many lives as we can is what drives our entire team, and this regulatory achievement means we are further on our way to accomplishing that goal.”

COBRA-OS is a 4 Fr aortic occlusion device that doesn’t require an over-the-wire technique. The company said it is one of the smallest life-saving Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) devices c…

Front Line Medical recently announced that it expanded the availability of its COBRA-OS aortic occlusion device to meet growing demands.

The Ontario, Canada-based company is increasing production of the COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) occluder following patient success rates and expanded interest from hospitals to treat trauma.

Get the full story on our sister site, Medical Tubing + Extrusion.

Front Line Medical Technologies today announced that its COBRA-OS bleeding control device won FDA 510(k) clearance.

The COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) is a 4 French REBOA (resuscitative endovascular balloon occlusion of the aorta) device that provides full occlusion, intermittent occlusion or partial occlusion depending on a patient’s needs.

Get the full story on our sister site, Medical Tubing + Extrusion.